Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00004158. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Alternate Day Dosing of Pomalidomide in Patients With Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03520985. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pomalidomide for Lenalidomide for Relapsed or Refractory Multiple Myeloma Patients
ClinicalTrials.gov study NCT02188368. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of PAD Versus Velcade, Cyclophosphamide and Dexamethasone (VCD) Treatment in Subjects With Multiple Myeloma
ClinicalTrials.gov study NCT01868828. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pomalidomide, Ixazomib, and Dexamethasone With or Without Intensification by Cyclophosphamide in Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03731832. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Clinical Trial of ITF2357 In Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00792506. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prevalence of Asymptomatic Thrombosis in Multiple Myeloma
ClinicalTrials.gov study NCT03145870. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CB-839 HCl in Combination With Carfilzomib and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03798678. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study for Validation of Target Therapy in Multiple Myeloma Cells From Patients With miRNAs Released From B Cells, and Study of the Bone Marrow Tumor Microenvironment (Microenvironment of MM)
ClinicalTrials.gov study NCT06154317. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Efficacy, Dose-finding Study of a Monoclonal Antibody in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00231166. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Universal BCMA-targeted LUCAR-B68 Cells in Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05498545. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Ixazomib, Thalidomide and Dexamethasone in Newly Diagnosed and Treatment-naive Multiple Myeloma (MM) Participants Non-eligible for Autologous Stem-cell Transplantation
ClinicalTrials.gov study NCT03608501. IPD Sharing: YES. Countries: 1. Publications: 0.
RDD Versus VDD in Newly Diagnosed Patients With Multiple Myeloma
ClinicalTrials.gov study NCT03908138. IPD Sharing: NO. Countries: 1. Publications: 0.
Ciltacabtagene Autoleucel in High-Risk Smoldering Multiple Myeloma
ClinicalTrials.gov study NCT06574126. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I/II Trial of Cord Blood-Derived NK Cells Genetically Engineered With NY-ESO-1 TCR/IL-15 Cell Receptor for Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06066359. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide After Reduced-intensity Allogeneic Stem Cell Transplantation for Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT01421927. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trisenox, Ascorbic Acid and Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00590603. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rationale for Cytogenetic Risk Stratification by Imaging Flow Cytometry in Multiple Myeloma
ClinicalTrials.gov study NCT03983486. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of an Accelerated Infusion Rate of Daratumumab in Patients With Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03697629. IPD Sharing: NO. Countries: 1. Publications: 0.
Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions
ClinicalTrials.gov study NCT00029224. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.